Marquis Health Consulting Services Marks America's 250th Anniversary with 'Home, anew,' a Tribute to Senior Stories of Belonging, Resilience and Community
Brick Township, New Jersey--(Newsfile Corp. - June 30, 2026) - In conjunction with America's historic semiquincentennial anniversary, the Marquis Health Consulting Services Senior Living team has proudly published 'Home, anew: 250 Voices of Belonging and Community, Celebrating Our Nation's 250th Year.' The commemorative book features over 250 stories and reflections from residents, family and team members across the senior living
Healthcare and Hospitals, Health
2026-06-30 12:31 PM EDT | Marquis Health Consulting Services
Envoy Medical Submits First Module of Modular Premarket Approval Application to the U.S. Food and Drug Administration for Breakthrough-Designated Device
White Bear Lake, Minnesota--(Newsfile Corp. - June 30, 2026) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing solutions, today announced the submission of the first module of its Modular Premarket Approval ("PMA") application to the U.S. Food and Drug Administration ("FDA") for its FDA Breakthrough Device-designated product. The submissi
Biotechnology, Healthcare and Hospitals
2026-06-30 8:30 AM EDT | Envoy Medical, Inc.
Illumisoft and Capgemini Collaborate to Advance Human-Safe Far UVC Platform for Airborne Pathogen Risk Reduction in High-Occupancy Indoor Environments
Vancouver, British Columbia--(Newsfile Corp. - June 30, 2026) - Illumisoft Lighting Corp. (TSXV: UVC) ("Illumisoft" or the "Company") is developing its SaniLux 216 nanometre far ultraviolet C ("far UVC") disinfection platform to enable the safe mitigation of airborne pathogen risk in high-occupancy indoor environments where people live, work, learn, travel, and gather. Today, the Company announced that it is taking steps to accelerate the platform's development. To support the path to m
Technology, Biotechnology, Healthcare and Hospitals, Household / Consumer / Cosmetics
2026-06-30 7:00 AM EDT | Illumisoft Lighting Corp.
This Fourth of July, Mitch Gould Reflects on the Entrepreneurial Spirit Behind the American Dream
Boca Raton, Florida--(Newsfile Corp. - June 30, 2026) - As Americans prepare to celebrate Independence Day, veteran entrepreneur and distribution executive Mitch Gould is reflecting on the entrepreneurial spirit that has defined both his own career and the opportunities available to innovators who pursue the American Dream. To view the full announcement, including downloadable images, bios, and more, click her
Food / Beverages, Healthcare and Hospitals
2026-06-30 6:06 AM EDT | Nutritional Products International
Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2026 and Provides Conference Call Information
Northvale, New Jersey--(Newsfile Corp. - June 29, 2026) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company developing niche generic products, announced results for the fiscal year ended March 31, 2026 ("Fiscal 2026"). Consolidated revenues for Fiscal 2026 were $148.9 million, an increase of $64.8 million or approximately 77% as compared to the comparable period of the prior fiscal year. Income from operations was $49.1 million
Healthcare and Hospitals, Pharmaceuticals, Health
2026-06-29 4:29 PM EDT | Elite Pharmaceuticals, Inc.
Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Live Virtual Non-Deal Roadshow Series
King of Prussia, Pennsylvania--(Newsfile Corp. - June 26, 2026) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its proprietary INTASYL® gene silencing technology to eliminate cancer. Phio Pharmaceuticals announced today that Robert Bitterman, CEO and Chairman of the Board, will present an overview of the Company's INTASYL® siRNA platform, including its lead clinical candidate PH-762
Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Health
2026-06-26 7:00 AM EDT | Phio Pharmaceuticals Corp.
HEALWELL AI Announces Voting Results of 2026 AGSM
Toronto, Ontario--(Newsfile Corp. - June 26, 2026) - HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) ("HEALWELL" or the "Company"), a healthcare artificial intelligence company focused on preventative care, is pleased to announce the voting results from its annual general and special meeting of the shareholders of the Company held on June 25, 2026 (the "Meeting"). Shareholders representing approximately 66.83% of the votes attributable to HEALWELL's outstanding sha
Technology, Healthcare and Hospitals
2026-06-26 5:42 AM EDT | HEALWELL AI
Resverlogix Announces Voting Results from the 2026 Meeting of Shareholders
Calgary, Alberta--(Newsfile Corp. - June 25, 2026) - Resverlogix Corp. (TSX: RVX) ("Resverlogix", or the "Corporation") today held its Annual Meeting of Shareholders (the "Meeting") in Calgary, Alberta. During business proceedings at the Meeting, shareholders elected Five (5) Board members until the next annual meeting. The voting results of shares represented at the Meeting for individual directors were as follows:
Technology, Biotechnology, Healthcare and Hospitals
2026-06-25 9:12 PM EDT | Resverlogix Corp.
Medexus Announces Fiscal Year 2026 Results, Demonstrating Continued Momentum and Strong Product-Level Performance of GRAFAPEX (treosulfan) for Injection
Ontario and Chicago, Illinois--(Newsfile Corp. - June 25, 2026) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) today announced its operating and financial results and provided a business update for the company's fourth fiscal quarter and fiscal year ended March 31, 2026 (the company's fiscal Q4 2026 and fiscal year 2026). All dollar amounts in this news release are in US dollars unless specified otherwise. Company overview Medexus is currently focused on deliv
Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Health
2026-06-25 6:00 PM EDT | Medexus Pharmaceuticals Inc.
Veritas Association Management Recognized by Association Management Company Institute with Excellence in Client Advancement Award
Chicago, Illinois--(Newsfile Corp. - June 25, 2026) - Veritas Association Management has been selected as the recipient of the 2026 Client Excellence Award from the AMC Institute (AMCI), recognizing the company's outstanding leadership, innovation and commitment to helping an association navigate a period of significant organizational challenge and transformation. The Client Excellence Award honors association management companies that demonstrate exceptional service and measurable impa
2026-06-25 10:47 AM EDT | Veritas Association Management
Envoy Medical Terminates At-the-Market (ATM) Equity Facility
White Bear Lake, Minnesota--(Newsfile Corp. - June 25, 2026) - Envoy Medical®, Inc. (NASDAQ: COCH) ("Envoy Medical"), a hearing health company pioneering fully implanted hearing solutions, today announced that it has formally terminated its at-the-market equity facility (the "ATM Facility"). The ATM Facility, under which the Company was previously authorized to offer and sell up to $15 million worth of shares of its com
Biotechnology, Healthcare and Hospitals
2026-06-25 8:30 AM EDT | Envoy Medical, Inc.
Phio Pharmaceuticals Announces "How siRNA Therapy can Change the Course of Cancer Treatment" in a Fireside Chat with Force Family Office on Monday, June 29, 2026
King of Prussia, Pennsylvania--(Newsfile Corp. - June 25, 2026) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its proprietary INTASYL® gene silencing technology to eliminate cancer. Phio announced today that Mr. Robert Bitterman, CEO and Chairman of the Board, Phio Pharmaceuticals will participate in a fireside chat with Harvey Briggs, Chief Communications Officer, Force Family Office. Joining the
Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Health
2026-06-25 7:00 AM EDT | Phio Pharmaceuticals Corp.
Illumisoft Appoints Former White House Chief Healthcare Economist Jonathan Ketcham as Strategic Advisor
Vancouver, British Columbia--(Newsfile Corp. - June 25, 2026) - Illumisoft Lighting Corp. (TSXV: UVC) ("Illumisoft" or the "Company") today announced the appointment of Jonathan Ketcham as a strategic advisor to the Company. Dr. Ketcham brings deep expertise in healthcare economics, public policy, reimbursement, procurement, and technology adoption. His guidance is expected to benefit Illumisoft greatly as it advances its ultraviolet germicidal technology platform toward commercializati
Technology, Biotechnology, Healthcare and Hospitals, Household / Consumer / Cosmetics
2026-06-25 7:00 AM EDT | Illumisoft Lighting Corp.
Phio Pharmaceuticals Reaches Key Milestone in Advancing Lead Candidate PH-762
King of Prussia, Pennsylvania--(Newsfile Corp. - June 24, 2026) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage siRNA biopharmaceutical company focused on developing therapeutics using its proprietary INTASYL® gene silencing technology to eliminate cancer, today
Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Health
2026-06-24 7:00 AM EDT | Phio Pharmaceuticals Corp.
BioMark Diagnostics Secures Landmark Canadian and European Patent Allowances for Early-Stage Lung Cancer Blood Test
Vancouver, British Columbia--(Newsfile Corp. - June 23, 2026) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTCQB: BMKDF) ("BioMark" or the "Company"), a leading developer of liquid biopsy technologies focused on the early detection of lung cancer through metabolomics, today announced a major operational milestone that underscores the strength of Canadian life sciences innovation. Coinciding with the global spotlight on Canadian medical innovation taking the stage at the BIO Int
Technology, Biotechnology, Healthcare and Hospitals
2026-06-23 8:30 AM EDT | BioMark Diagnostics, Inc.
Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Fiscal Year 2026 Financial Results on June 30, 2026
Northvale, New Jersey--(Newsfile Corp. - June 23, 2026) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company developing niche generic products, announced today that it will release its 2026 year-end financial results on Monday, June 29, 2026. Elite's management will host a live conference call on Tuesday, June 30th, at 11:30 AM EDT to discuss the company's financial and operating results and provide a general business update. St
Healthcare and Hospitals, Pharmaceuticals, Health
2026-06-23 7:00 AM EDT | Elite Pharmaceuticals, Inc.
Richards Group Inc. Announces June 2026 Dividend
Toronto, Ontario--(Newsfile Corp. - June 19, 2026) - Richards Group Inc. (TSX: RIC) (the "Company") announced today its cash dividend for the month ended June 30, 2026 of Cdn$0.11 per share. This dividend will be to shareholders of record at the close of business on June 30, 2026 and will be payable on July 14, 2026. Shareholders who are non-residents of Canada may be required to pay all withholding taxes payable in respect of any dividends of income by the Company, whether such dividends a
Healthcare and Hospitals, Household / Consumer / Cosmetics, Pharmaceuticals
2026-06-19 11:14 AM EDT | Richards Group Inc.
Veritas Association Management Expands Strategic Planning Services for Healthcare Associations
Chicago, Illinois--(Newsfile Corp. - June 18, 2026) - Veritas Association Management, a leading association management company serving healthcare and medical specialty organizations, has expanded its service offerings to include strategic planning and board facilitation services designed specifically for healthcare associations. The new service helps boards and leadership teams develop actionable strategic roadmaps while navigating the rapidly changing healthcare environment, including
2026-06-18 2:43 PM EDT | Veritas Association Management
Envoy Medical to Present at Investor Conferences on June 25th
White Bear Lake, Minnesota--(Newsfile Corp. - June 18, 2026) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing solutions, today announced that Brent Lucas, CEO of Envoy Medical, will present at the Virtual Life Sciences Investor Forum and the Biotech Webull Webinar Panel on June 25, 2026. Life Sciences Virtual Investor Forum
Biotechnology, Healthcare and Hospitals
2026-06-18 8:30 AM EDT | Envoy Medical, Inc.
Phio Pharmaceuticals Announces Participation in the Life Sciences Investor Forum on June 24-25, 2026
King of Prussia, Pennsylvania--(Newsfile Corp. - June 18, 2026) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its proprietary INTASYL® gene silencing technology to eliminate cancer. Phio Pharmaceuticals announced today that Robert Bitterman, CEO and Chairman of the Board, will present an overview of the Company's INTASYL® siRNA platform, including its lead clinical candidate PH-762
Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Health
2026-06-18 7:00 AM EDT | Phio Pharmaceuticals Corp.